Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy

被引：0

作者：

Vojtech Kratky

Anna Valerianova

Zdenka Hruskova

Vladimir Tesar

Jan Malik

机构：

[1] Charles University and General University Hospital in Prague,Department of Nephrology, First Faculty of Medicine

[2] Charles University and General University Hospital in Prague,3rd Department of Internal Medicine, First Faculty of Medicine

来源：

Current Atherosclerosis Reports | 2024年 / 26卷

关键词：

Cardiovascular Disease; Vascular Pathology; Chronic Kidney Disease; Dyslipidemia; Lipid-lowering Drugs;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：103 / 109

页数：6

共 50 条

[41] Intensive lipid-lowering therapy in high-risk diabetic patients
Masaaki Miyata
Hypertension Research, 2021, 44 : 1676 - 1677
[42] Intensive lipid-lowering therapy in high-risk diabetic patients
Miyata, Masaaki
HYPERTENSION RESEARCH, 2021, 44 (12) : 1676 - 1677
[43] Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease
Karalis, Dean G.
CURRENT OPINION IN LIPIDOLOGY, 2023, 34 (06) : 252 - 258
[44] Lipid-lowering in CKD—at the SHARP end of the evidence?
Suetonia C. Palmer
Giovanni F. M. Strippoli
Nature Reviews Nephrology, 2011, 7 : 609 - 611
[45] THE ROLE OF DIET IN PATIENTS WHO ARE ON LIPID-LOWERING DRUG-THERAPY
CHISHOLM, A
CURRENT OPINION IN LIPIDOLOGY, 1993, 4 (01) : 17 - 20
[46] Hyperlipidaemia in Paediatric Patients The Role of Lipid-Lowering Therapy in Clinical Practice
Wimbicki, Anthony S.
Vijoen, Adie
DRUG SAFETY, 2010, 33 (02) : 115 - 125
[47] Usefulness of lipid-lowering therapy in elderly patients
Wenger, NK
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (08): : 870 - +
[48] Lipid-lowering Drug Therapy in Elderly Patients
Berthold, Heiner K.
Gouni-Berthold, Ioanna
CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (09) : 877 - 893
[49] Effectiveness of lipid-lowering therapy in HIV patients
Martinez, Esteban
Leyes, Pere
Ros, Emilio
CURRENT OPINION IN HIV AND AIDS, 2008, 3 (03) : 240 - 246
[50] The indication for lipid-lowering therapy and its intensity is based on the cardiovascular risk, not on the level of cholesterol
Parhofer K.G.
MMW - Fortschritte der Medizin, 2024, 166 (5) : 52 - 53

← 1 2 3 4 5 →